Hindilerden, FehmiHindilerden, İpek YonalPınarbaşı Şimşek, BinnurHançer, Veysel SabriKaymakoğlu, SabahattinKüçükkaya, Reyhan DizNalçacı, Meliha2020-08-302020-08-302019Hindilerden, F., Hindilerden, I. Y., Pinarbasi, B., Hancer, V. S., Kaymakoglu, S., Kucukkaya, R. D., & Nalcaci, M. (2019). The clinical significance of jak2v617f mutation for philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchic vein thrombosis.2152-26502152-2669https://doi.org/10.1016/j.clml.2019.07.377https://hdl.handle.net/20.500.12713/574Context: High prevalence of JAK2V617F mutation in splanchic vein thrombosis (SVT), including Budd-Chiari syndrome (BCS) and portal vein thrombosis (PVT) raised suspicion of an underlying Philadelphiaenegative chronic myeloproliferative disease (MPD).eninfo:eu-repo/semantics/closedAccessMpnMyeloproliferative NeoplasmsJak2v617f MutationPhiladelphia-Negative Chronic Myeloproliferative NeoplasmsSplanchic Vein ThrombosisThe clinical significance of jak2v617f mutation for philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchic vein thrombosisConference Object19S357S357WOS:000483480700408Q310.1016/j.clml.2019.07.377